Cognitive Dysfunction Across Mental Disorders and its Relation to Suicidality
October 25, 2024
A recent study examined the relationship between cognitive function...
Read More
October Is ADHD Awareness Month
October 13, 2024
October is ADHD Awareness Month. The goal of ADHD Awareness Month i...
Read More
Medication-Induced Weight Change Across Common Antidepressant Treatments
October 9, 2024
While antidepressants rank among the most frequently prescribed dru...
Read More
Inflammatory Biomarkers and Risk of Psychiatric Disorders
October 5, 2024
A recent study investigates whether certain inflammatory markers i...
Read More
FDA Approves First Muscarinic Agonist for Schizophrenia
September 26, 2024
The U.S. Food and Drug Administration has approved xanomeline-tros...
Read More
Poor Sleep Associated with Poorer Antidepressant Response
September 23, 2024
Poor sleep is common in treatment-resistant late-life depression an...
Read More
Positive Phase 2 Data for NBI-1117568 in Adults with Schizophrenia
September 14, 2024
A new era of treatment strategies seems to be dawning with an incre...
Read More
Mortality Risk In Long-Acting Injectable Versus Oral Antipsychotics In Schizophrenia
September 9, 2024
Individuals with schizophrenia often struggle with consistently tak...
Read More
Smoking Cessation as a Priority for Psychiatrists
September 2, 2024
Smoking rates remain disproportionately high among individuals with...
Read More
Combination OUD Treatment Safe During Pregnancy
August 26, 2024
A recent study explored the comparative safety of prenatal exposure...
Read More
Bright Light Exposure, Depression Symptoms, and Sleep Regularity
August 16, 2024
Bright light therapy is typically used to manage circadian rhythm d...
Read More
Disrupted Access to Prescription Stimulant Medications
August 12, 2024
The Centers for Disease Control and Prevention (CDC) recently issue...
Read More